Víctor E Reviglio

Victor Eduardo Reviglio received the M.D. degree from the Catholic University of Cordoba, Cordoba, Argentina, in 1995. He has been a Professor of ophthalmology at The National University of La Plata, Buenos Aires, since 2002. He was a Corneal Research Fellow at the Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, USA, in 1999–2001. In addition, he made a research study in infectious eye diseases and molecular biology at the Wilmer Eye Institute, Johns Hopkins University, in 2000-2001. He completed his Ph.D. thesis in medicine at the Catholic University of Cordoba, in November 2006, and working at the university as Ophthalmology Professor and Researcher. Actually, he is a chief of the Ophthalmology Service of Cordoba Hospital and the director of Eye Bank and Corneal Transplant Department at Cordoba Hospital, Cordoba, Argentina.

Profesor Doctor Victor E. Reviglio

ANTECEDENTES ACADEMICOS / PROFESIONALES

TITULO UNIVERSITARIO: MEDICO UNIV. CATOLICA DE CORDOBA 1990-1995 Córdoba, Argentina

ENTRENAMIENTO DE PREGRADO: UNIV. CATOLICA de CORDOBA (Períodos de seis meses intrahospitalarios) Inmunología con examen final Diagnóstico por Imágenes I Diagnóstico por Imágenes II Genética Médica Rehabilitación Médica

ENTRENAMIENTO INTENSIVO: HOSPITAL CENTRAL de RECONQUISTA Clínica Médica (examen final: 10 Diez) Reconquista, Santa Fe, Argentina

RESIDENCIA: CENTRO PRIVADO DE OJOS ROMAGOSA Marzo 1996 - Abril 1999 Córdoba, Argentina Aprobada y categorizada “B” (muy buena) por CONEAU desde 1996 hasta la fecha

ESPECIALIDAD: OFTALMOLOGIA M.E. 448019 Colegio de Médicos Distrito IV Buenos Aires – 2002 Universidad Nacional de La Plata Consejo de Médicos de la Provincia de Córdoba MP: 24505 ME: 10364

ENTRENAMIENTO DE POSTGRADO

FELLOWSHIP TRAINING -Corneal Research Fellow at the Wilmer eye Institute, Johns Hopkins University, School of Medicine, Baltimore, USA. September 1999 – December 2000. Head of Department: Terrence O’Brien, MD Cornea / External Diseases of the Eye, Refractive Surgery and Ocular Infectious Diseases.

BIOLOGIA MOLECULAR -Pediatric Ophthalmology and adult strabismus, TRAINING Hereditary Eye Diseases and Molecular Biology: Head of Department: Patrick Tong, MD, PhD. at the Wilmer Eye Institute, at Johns Hopkins University, School of Medicine, Baltimore, USA. June 2000 to December 2000.

DESEMPEÑO PROFESIONAL:

INSTRUCTOR DOCENTE: CENTRO PRIVADO DE OJOS ROMAGOSA Departamento de Oftalmología Jefe de Residentes 1998-1999 Córdoba, Argentina.

MIEMBRO DE STAFF: CENTRO PRIVADO DE OJOS ROMAGOSA Jefe del Departamento de Segmento anterior, Cornea y Cirugía Refractiva. 2001-2005

ASISTENTE EN COORDINACION DE: INTERNATIONAL BASIC SCIENCE AND CLINICAL SCIENCE ASSESSMENTS International Council of Ophthalmology Cambridge, England Venue: Córdoba, Argentina 1999 – 2005

INSTRUCTOR QUIRURGICO: Centro de Ojo Romagosa (2001-2005) S. Oftalmología, Hospital Córdoba (2003 a la fecha) Cirugías del Segmento anterior del ojo Cirugía Refractiva Cirugía Catarata Transplante de Cornea

DIRECTOR: Banco de Ojos de La Provincia de Córdoba Hospital Córdoba, 2005 hasta la fecha.

JEFE SERVICIO OFTALMOLOGIA: Hospital Córdoba. Marzo 2007 hasta la Fecha.

DOCENTE AUTORIZADO: Cátedra de Anatomía Patológica y Fisiopatología. (2004 a la fecha) Facultad de Medicina, Universidad Católica de Córdoba. PROFESOR AUTORIZADO: Catedra de Clinica oftalmologica. (2006 a la fecha) Facultad de Medicina, Universidad Católica de Córdoba.

PROFESOR ADJUNTO: Catedra de Clinica oftalmologica. (2007 a la fecha) Facultad de Medicina, Universidad Católica de Córdoba.

JEFE TRABAJOS PRACTICOS: Serv. Oftalmología, Hospital Córdoba. Cátedra de Clínica oftalmológica. (2006 a la fecha) Facultad de Medicina, Universidad Católica de Córdoba

TESIS DOCTORAL EN MEDICINA: Inhibidor de proteasas secretado por leucocitos: Su expresión en procesos cicatrizales, inflamatorios e infecciosos de la cornea y estructuras intra-oculares Universidad Católica de Córdoba Facultad de Medicina Noviembre 27 del 2006. COORDINADOR HOSPITALARIO Julio 2007 hasta la fecha De la RAO (Red Asistencial Oftalmológica)De la PROVINCIA de CORDOBAy en TRANSPALNTE DE CORNEA

Ophthalmology Research & Abril 2007 hasta la fecha.Molecular Biology Laboratory, Universidad Católica de Cordoba,Facultad de Medicina.

MEMBRESIAS:

- American Academy of Ophthalmology- American Society of Cataract and Refractive Surgery- Sociedad Argentina de Oftalmología - Consejo Argentino de Oftalmología- PanAmerican Association of Ophthalmology- The Association for Research in Vision and Ophthalmology (A.R.V.O.)- The Resident Association of the Wilmer Ophthalmological Institute- International Ocular Surface Society- National Keratoconus Foundation

PUBLICACIONES CON REFERATO INTERNACIONAL

1- Reviglio VE, Rodríguez ML, Picotti GS, Paradello M, Luna JD, Juárez CP: Mycobacterium Chelonae keratitis following laser in situ keratomileusis. J of Refract Surg 1998 May/June; 14(3) 357-60.

2-Reviglio VE, Luna JD, Rodríguez ML, García FE, Juárez CP: Laser in situ keratomileusis using the LaserSight 200 laser: results of 950 consecutive cases. J Cataract Refract Surg. 1999 Aug; 25(8):1062-8. 3-Luna JD, Reviglio VE, Juárez CP: Bilateral macular hemorrhage after laser in situ keratomileusis. Graefe’s Archive for Clinical and Experimental Ophthalmology 1999, 237(7):611-613.

4-Reviglio VE, Bossana EL, Luna JD, Juárez CP:Results of 300 consecutive LASIK for refractive errors using the LaserSight 200 Excimer Laser with software 9.0 J Refract Surg. 2000 Nov-Dec;16(6):716-23.

5- Reviglio VE, Muiño JC, Luna JD, Juarez CP. Cirugía bilateral: el mejor modo de realizar nomogramas personalizados de LASIK [Bilateral surgery: an efficient manner of creating LASIK nomograms] Rev Fac Cien Med Univ Nac Cordoba. 2000;57(1):89-93. Spanish.

6- Luna JD, Artal MN, Reviglio VE, Pelizzari M, Juarez CP: Vitreoretinal alterations following laser in situ keratomileusis. Graefes Arch Clin Exp Ophthalmol. 2001 Jul;239(6):416-23.

7- Ashraf MF, Li Q, Reviglio VE, Rana TS, Green WR, O’Brien TP: Ulcerative keratolysis with perforation after postoperative diclofenac use: Upregulation of matrix metalloproteinases (MMPS). Ophthalmology. 2001 Apr;108(4):656-9.

8- Li QJ, Ashraf FM, Rana TS, Tuli S, Mai EL, Adler RA, Reviglio VE, O'Brien TP. Long-term survival of allogeneic donor cell-derived corneal epithelium in limbal deficient rabbits. Curr Eye Res. 2001 Nov;23(5):336-45.

9-Luna JD, Artal MN, Reviglio VE, Juarez CP: Laser in situ keratomileusis -induced optic neuropathy. Ophthalmology 2002, May 109(5):817-8

10- Artal MN, Rodriguez ML, Luna JD, Reviglio VE, Cuello O, Muiño JC, Juarez CP.: Giant cell arteritis in a Hispanic population. Ophthalmology 109 (10):1757.

11- Cuello OH, Caorlin MJ, Reviglio VE, Carvajal L, Palacio de Guerra E, Luna JD, Juarez CP: Rhodococcus Globerulus keratitis following laser in situ keratomileusis. J of Cataract and Refractive Surg. 2002 Dec; 28(12):2235-7.

12- Iribarren M, Reviglio VE, Luna JD, Juarez CP: Endoftalmitis endógena por cándidas. MEDICINA (Buenos Aires) 2002; 62:584.

13- Sambuelli R, Luna JD, Reviglio VE, Aoki A, Juarez CP.Small choroidal melanoma with massive extraocular extension: invasion through posterior scleral emissary channels. Int Ophthalmol. 2001;24(4):213-8.

14- Reviglio VE, Rana TS, Li Q, Ashraf MF, Daly MK, O’Brien TP: Effect of topical nonsteroidal anti-inflammatory agents on the expression of matrix metalloproteinases in the cornea. Cataract & Refractive Surgery. 2003 May;29(5):989-97.

15- Luna JD, Caribaux LJ, Reviglio VE, Juarez CP. Lens-sparing surgery for retinopathy of prematurity.Ophthalmology. 2003 Aug;110(8):1669.

16- Reviglio VE, Hakim MA, Song JK, O'Brien TP. Effect of topical fluoroquinolones on the expression of matrixmetalloproteinases in the cornea.BMC Ophthalmol. 2003 Oct 6;3(1):10.

17- Hwang TS, Hyon JY, Song JK, Reviglio VE, Spahr HT, O'Brien TP. Disinfection capacity of PuriLens contact lens cleaning unit againstAcanthamoeba.Eye Contact Lens. 2004 Jan;30(1):42-3.

18- Smith RJ, Yadarola MB, Pelizzari MF, Luna JD, Juarez CP, Reviglio VE. Complete bilateral vitreous detachment after LASIK retreatment.J Cataract Refract Surg. 2004 Jun;30(6):1382-4.

19- Luna JD, Reviglio VE, Artal MN, Juarez CP. Proposed mechanism for retinal tears after LASIK.Ophthalmology. 2005 Feb;112(2):359.

20- Smith RJ, Caribaux LJ, Reviglio VE, Lenta J, Juarez CP, Luna JD. [Submacular surgery in ocular toxocariasis: a clinic-pathologic correlation] Rev Fac Cien Med Univ Nac Cordoba. 2003;60(1):61-6.

21- J.C. Muiño, M.A. Ordoñez, Reviglio VE, M. Ferrero, M.D. Romero and C.P. Juárez Occupational rhinitis and asthma induced by corneal antigens in surgeons and close surgical assistants following Lasik. Journal of Allergy and Clinical Immunology, Volume 115, Issue 2, Supplement 1, February 2005, Page S28

22- Reviglio VE, M. Romero, M. Ferrero, J. Luna, C. Juárez, J. MuiñoSerum Leukocyte Protease Inhibitor Levels in Patients with Uveitis. Journal of Allergy and Clinical Immunology, 2006; Volume 117, Issue 2, Pages S169-S169

23- Reviglio VE, Kuo IC, Gramajo L, Olmedo MA, Falco M, Juarez CP.Acute Rhegmatogenous retinal detachment immediately following laser in situ keratomileusis. J Cataract Refract Surg. 2007 March.

24- Reviglio VE, Sambuelli RH, Olmedo A, Falco M, Echenique J, O'Brien TP, Kuo IC. Secretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitis. Mediators Inflamm. 2007;2007:93857.

25- Kuo IC, Falco M, Olmedo A, Misani L, O'Brien TP, Reviglio VE.Corneal tattoo with tea infusion.Food Chem Toxicol. 2008 Jun;46(6):2303-5

26- Kuo IC, Haller JA, Maffrand R, Sambuelli RH, Reviglio VE.Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment.Arch Ophthalmol. 2008 Sep;126(9):1311-3.